Phase III share of oncology trials
RecordSTO-YTT2F4AQ8A-HM1A94QN2Z-DYEYSF
Global · 2024
Phase III share of oncology trials worldwide was 14% in 2024 (IQVIA).
Phase III share of oncology trials: every country and year, and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Other Findings
- Retrieved
- 16 Sep 2026
- Status
- Verified
What the source says
Phase II trials, including Phase I/II, IIa and IIb, represent the largest share of trials, with 48% of oncology trials started in 2024 being Phase II compared to 38% Phase I and 14% Phase III.
Checked: the figure 14%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2024). Global Oncology Trends 2025. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Via StatOrigin, https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Global Oncology Trends 2025." 2024, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed 16 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF.
- Chicago
- IQVIA Institute. "Global Oncology Trends 2025." 2024. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF.
- BibTeX
- @misc{iqvia2024phasedyeysf, author = {{IQVIA Institute}}, title = {Global Oncology Trends 2025}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Global Oncology Trends 2025
- Type
- Press release
- Published
- —
- Locator
- Other Findings
- Retrieved
- 16 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_YTT2F4AQ8AHM1A94QN2ZDYEYSF